Cytheris, Centre Léon Bérard and ImmunID announce initiation of clinical trial to evaluate combination regimen of IL-7 (CYT107) and XELODA (R) (capecitabine) in treatment of metastatic breast cancer
13-May-2011 -
Cytheris SA, the Centre Léon Bérard and ImmunID Technologies SAS announced initiation of a Phase IIa clinical trial that will evaluate multiple combinations of recombinant human interleukin-7 (CYT107), the investigational multifunctional cytokine under development by Cytheris, and a ...
breast cancer
chemotherapy
lymphopenia
+2